Pt(IV) derivatives of oxaliplatin conjugated with dichloroacetate were synthesized.
Conjugates display markedly enhanced activity in cisplatin resistant tumor cells.
DCA released in cancer cells affects mitochondria and metabolism of glucose.
Conjugates activate an autophagic response in cancer cells.
Toxicity of the conjugates in cancer cells can be potentiated by 5-fluorouracil.